Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
Article in Exploration of Targeted Anti-tumor Therapy (October 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer
Article in Journal of Immunotherapy (April 2021)
The ups, downs and new trends of IDO1 inhibitors
Article in Bioorganic Chemistry (March 2021)